Hayley D. McKeen - Concepedia

Author

Hayley D. McKeen

Also Known As

H D McKeen, H McKeen, H. D. McKeen, H.D. McKeen, HD McKeen, Hayley D McKeen, Hayley D. McKeen, Hayley McKeen, Hayley D. McKeen

Publications

549

Citations

H-Index

Concepts

All Affiliations

Queen's University Belfast University of Ulster Cancer Research UK University of Liverpool University of Birmingham

About

Hayley D. McKeen is an author at Queen's University Belfast specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	201
2	Cell Biology	4	4	201
3	Natural Sciences	2	2	116
4	Endocrinology	2	2	117
5	Cellular Physiology	1	1	46

Hayley D. McKeen

Publications

484

Citations

H-Index

Page 1

	Year	Citations
Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway Lana McClements, Anita Yakkundi, Angelos Papaspyropoulos, Clinical Cancer Research	2013	78
RALA-Mediated Delivery of FKBPL Nucleic Acid Therapeutics R. Avery Bennett, Anita Yakkundi, Hayley D. McKeen, Nanomedicine	2015	74
A Novel FK506-Like Binding Protein Interacts with the Glucocorticoid Receptor and Regulates Steroid Receptor Signaling Hayley D. McKeen, Kerry McAlpine, Andrea Valentine, Endocrinology ImmunologyMolecular BiologyGlucocorticoidGlucocorticoid Receptor90-Glucocorticoid Receptor	2008	70
FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism Andrea Valentine, Martin O’Rourke, Anita Yakkundi, Clinical Cancer Research	2011	67
FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis Anita Yakkundi, R. Avery Bennett, Ivette Hernández-Negrete, Arteriosclerosis Thrombosis and Vascular Biology	2015	50
FKBPL Regulates Estrogen Receptor Signaling and Determines Response to Endocrine Therapy Hayley D. McKeen, Christopher Byrne, Puthen V. Jithesh, Cancer Research Breast OncologyImmunologyEndocrine TherapyDetermines ResponseCell Signaling	2010	47
The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway Anita Yakkundi, Lynn McCallum, Anthony A. O’Kane, PLoS ONE ImmunologyMolecular BiologyCell DeathCellular PhysiologyCd44 Expression	2013	46
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen C Donley, Keeva McClelland, Hayley D. McKeen, Oncogene Tumor BiologyMedicineTumor GrowthReceptor Tyrosine KinaseNovel Regulator	2013	38
Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk W. K. Kaufmann, Leonid V. Filatov, Stephen E. Oglesbee, Carcinogenesis	2006	14

Page 1